CRC patients with overexpression of both YAP and TAZ have worse outcomes than those who have either one alone [74], and a YAP/TAZ gene expression signature was significantly associated with worse overall survival and more frequent metastasis in lung adenocarcinoma patients [69]. The gene discussed is YAP1; the disease is lung adenocarcinoma.